{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:52:13Z","timestamp":1791845533116,"version":"4.3.4"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Support Foundation of the Federal District (FAP-DF)","award":["0193.000961\/2015"],"award-info":[{"award-number":["0193.000961\/2015"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.10.073","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:18:37Z","timestamp":1509495517000},"page":"1779-1789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":234,"special_numbering":"C","title":["Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review"],"prefix":"10.1016","volume":"143","author":[{"given":"Larizza Hellen Santana","family":"Matos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Teixeira","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Alberto","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-9177","authenticated-orcid":false,"given":"Mauricio","family":"Homem-de-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.10.073_bib1","first-page":"360","article-title":"The urea-aldehyde derivatives of acetoacetic esters","volume":"23","author":"Biginelli","year":"1893","journal-title":"Gazz. Chim. Ital."},{"key":"10.1016\/j.ejmech.2017.10.073_bib2","first-page":"1934","article-title":"Rea\u00e7\u00f5es multicomponentes: um breve hist\u00f3rico e a versatilidade destas rea\u00e7\u00f5es na s\u00edntese de mol\u00e9culas bioativas","volume":"8","author":"Rogerio","year":"2016","journal-title":"Rev. Virtual Quim"},{"key":"10.1016\/j.ejmech.2017.10.073_bib3","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1021\/ja00807a040","article-title":"Synthesis of 3, 4-dihydro-2 (1H)-pyrimidinones and the mechanism of the Biginelli reaction","volume":"95","author":"Sweet","year":"1973","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.10.073_bib4","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1021\/jo971010u","article-title":"A\u00a0reexamination of the mechanism of the Biginelli dihydropyrimidine synthesis. Support for an N-Acyliminium ion intermediate1","volume":"62","author":"Kappe","year":"1997","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib5","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/chem.201204314","article-title":"The biginelli reaction with an imidazolium-tagged recyclable iron catalyst: kinetics, mechanism, and antitumoral activity","volume":"19","author":"Ramos","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.ejmech.2017.10.073_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.286.5441.971","article-title":"Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen","volume":"286","author":"Mayer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.10.073_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0223-5234(00)01189-2","article-title":"Biologically active dihydropyrimidones of the Biginelli-type \u2014 a literature survey","volume":"35","author":"Kappe","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1083\/jcb.150.5.975","article-title":"Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5","volume":"150","author":"Kapoor","year":"2000","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib9","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1074\/jbc.M413140200","article-title":"Monastrol inhibition of the mitotic kinesin Eg5","volume":"280","author":"Cochran","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/bi026716j","article-title":"Interaction of the mitotic inhibitor monastrol with human kinesin Eg5","volume":"42","author":"DeBonis","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2017.10.073_bib11","article-title":"Investigating the inhibition of bipolar spindle formation by monastrol, a small molecule kinesin inhibitor","volume":"10","author":"Kapoor","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2017.10.073_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.saa.2014.08.050","article-title":"Centrin: another target of monastrol, an inhibitor of mitotic spindle","volume":"137","author":"Duan","year":"2015","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2017.10.073_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chembiol.2009.05.011","article-title":"Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects","volume":"16","author":"Abassi","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ardp.201000402","article-title":"Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitors","volume":"344","author":"Zhu","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2017.10.073_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tet.2014.11.022","article-title":"Useful four-carbon synthons en route to monastrol analogs","volume":"71","author":"Abdou","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2017.10.073_bib16","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.bmcl.2004.01.039","article-title":"Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivatives","volume":"14","author":"Bahekar","year":"2004","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.bmcl.2005.11.043","article-title":"Antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones and its effects on arterial pressure in rats","volume":"16","author":"Bryzgalov","year":"2006","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib18","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1016\/j.ejmech.2011.09.023","article-title":"1,3-dihydro-2H-indol-2-ones derivatives: design, Synthesis, in\u00a0vitro antibacterial, antifungal and antitubercular study","volume":"46","author":"Akhaja","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bmc.2005.09.014","article-title":"Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: novel compounds against aspergillosis","volume":"14","author":"Chhillar","year":"2006","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib20","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.bmcl.2012.01.133","article-title":"A\u00a0novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability","volume":"22","author":"Kim","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00436-009-1557-z","article-title":"An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1","volume":"105","author":"Singh","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ejmech.2013.01.043","article-title":"Synthesis, evaluation and absolute configuration assignment of novel dihydropyrimidin-2-ones as picomolar sodium iodide symporter inhibitors","volume":"62","author":"Lacotte","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib23","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00044-014-1253-0","article-title":"Design, synthesis, and evaluation of dihydropyrimidinone (DHPM) based muscarinic receptor antagonist","volume":"24","author":"Acharya","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib24","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.bmcl.2014.04.099","article-title":"Graphite catalyzed solvent free synthesis of dihydropyrimidin-2(1H)-ones\/thiones and their antidiabetic activity","volume":"24","author":"Dhumaskar","year":"2014","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib25","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1016\/j.bmcl.2006.03.102","article-title":"Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4","volume":"16","author":"Blackburn","year":"2006","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bioorg.2016.10.002","article-title":"Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors","volume":"69","author":"Ahmad","year":"2016","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bioorg.2015.12.007","article-title":"Dihydropyrimidine based hydrazine dihydrochloride derivatives as potent urease inhibitors","volume":"64","author":"Khan","year":"2016","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/jm00106a048","article-title":"Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1, 2, 3, 4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents","volume":"34","author":"Atwal","year":"1991","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib29","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1016\/j.bmc.2015.09.009","article-title":"Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers","volume":"23","author":"Chikhale","year":"2015","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib30","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1021\/bi100119t","article-title":"Dihydropyrimidinone positive modulation of delta-subunit-containing gamma-aminobutyric acid type a receptors, including an epilepsy-linked mutant variant","volume":"49","author":"Lewis","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2017.10.073_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jare.2014.10.006","article-title":"A\u00a0mini-review on Biginelli adducts with notable pharmacological properties","volume":"6","author":"de F\u00e1tima","year":"2015","journal-title":"J.\u00a0Adv. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib32","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cmdc.201000252","article-title":"Structure-activity relationships and molecular docking of novel dihydropyrimidine-based mitotic Eg5 inhibitors","volume":"5","author":"Prokopcova","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.10.073_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejmech.2004.06.001","article-title":"One pot synthesis of thiazolodihydropyrimidinones and evaluation of their anticancer activity","volume":"39","author":"Holla","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejmech.2006.09.003","article-title":"Convenient one pot synthesis of some novel derivatives of thiazolo[2,3-b]dihydropyrimidinone possessing 4-methylthiophenyl moiety and evaluation of their antibacterial and antifungal activities","volume":"42","author":"Ashok","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib35","first-page":"197612","article-title":"Microwave-assisted synthesis and biological evaluation of dihydropyrimidinone derivatives as anti-inflammatory, antibacterial, and antifungal agents","volume":"2013","author":"Bhatewara","year":"2013","journal-title":"Int. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2013.10.003","article-title":"Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity","volume":"70","author":"Awadallah","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2014.09.096","article-title":"Biological evaluation of halogenated thiazolo[3,2-a]pyrimidin-3-one carboxylic acid derivatives targeting the YycG histidine kinase","volume":"87","author":"Zhao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/jhet.1657","article-title":"Synthesis of pyrimidine, dihydropyrimidinone, and dihydroimidazole derivatives under free solvent conditions and their antibacterial evaluation","volume":"51","author":"Soliman","year":"2014","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1590\/S0100-40422010000300037","article-title":"Propriedades qu\u00edmico-qu\u00e2nticas empregadas em estudos das rela\u00e7\u00f5es estrutura-atividade","volume":"33","author":"Arroio","year":"2010","journal-title":"Quim Nova"},{"key":"10.1016\/j.ejmech.2017.10.073_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmech.2017.03.025","article-title":"Recent synthetic and medicinal perspectives of dihydropyrimidinones: a review","volume":"132","author":"Kaur","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/2008-2231-21-70","article-title":"Synthesis and molecular modeling of six novel monastrol analogues: evaluation of cytotoxicity and kinesin inhibitory activity against HeLa cell line","volume":"21","author":"Abnous","year":"2013","journal-title":"Daru"},{"key":"10.1016\/j.ejmech.2017.10.073_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bmcl.2010.12.022","article-title":"Synthesis and in\u00a0vitro cytotoxicity evaluation of some fluorinated hexahydropyrimidine derivatives","volume":"21","author":"Agbaje","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129255","article-title":"Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol","volume":"10","author":"Asraf","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.10.073_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1747-0285.2009.00937.x","article-title":"Microwave-Assisted solvent-free synthesis of bis(dihydropyrimidinone)benzenes and evaluation of their cytotoxic activity","volume":"75","author":"Azizian","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2017.10.073_bib45","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1007\/s00044-011-9925-5","article-title":"Synthesis, characterization and anticancer activity of 3-aza-analogues of DP-7","volume":"21","author":"Bariwal","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21121746","article-title":"Targeting cancer stem cells with novel 4-(4-substituted phenyl)-5-(3,4,5-trimethoxy\/3,4-dimethoxy)-benzoyl-3,4-dihydropyrimidine -2(1H)-one\/thiones","volume":"21","author":"Bhat","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.10.073_bib47","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.molonc.2014.06.007","article-title":"Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer","volume":"8","author":"Brandl","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1590\/S0103-50532011000700025","article-title":"Synthesis of dihydropyrimidin-2-one\/thione library and cytotoxic activity against the human U138-MG and Rat C6 glioma cell lines","volume":"22","author":"Canto","year":"2011","journal-title":"J.\u00a0Braz Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.10.073_bib49","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/1535-7163.MCT-06-0201","article-title":"Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint","volume":"5","author":"Chin","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2017.10.073_bib50","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.bmc.2012.02.036","article-title":"Free radical scavenging and antiproliferative properties of Biginelli adducts","volume":"20","author":"da Silva","year":"2012","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cmdc.200900527","article-title":"Design and in\u00a0vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents","volume":"5","author":"Falciani","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.10.073_bib52","first-page":"1837","article-title":"A\u00a0Monastrol-derived Compound, LaSOM 63, inhibits Ecto-5 ' nucleotidase\/CD73 activity and induces apoptotic cell death of glioma cell lines","volume":"34","author":"Figueiro","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.200500005","article-title":"Development and biological evaluation of potent and specific inhibitors of mitotic kinesin eg5","volume":"6","author":"Gartner","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2017.10.073_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ica.2015.09.012","article-title":"Copper(I) complexes of methyl 4-aryl-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylates. Synthesis, characterization and activity in human breast cancer cells","volume":"438","author":"Gonzalez-Ballesteros","year":"2015","journal-title":"Inorganica Chim. Acta"},{"key":"10.1016\/j.ejmech.2017.10.073_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1274-1","article-title":"Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features","volume":"15","author":"Guido","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2017.10.073_bib56","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1039\/C5NJ02444G","article-title":"MoO2Cl2 catalyzed efficient synthesis of functionalized 3,4-dihydropyrimidin-2(1H)-ones\/thiones and polyhydroquinolines: recyclability, fluorescence and biological studies","volume":"40","author":"Guggilapu","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib57","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1021\/jm100421n","article-title":"Structural basis for inhibition of Eg5 by dihydropyrimidines: stereoselectivity of antimitotic inhibitors enastron, dimethylenastron and fluorastrol","volume":"53","author":"Kaan","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib58","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.ejmech.2011.04.048","article-title":"Synthesis and biological evaluation of conformationally flexible as well as restricted dimers of monastrol and related dihydropyrimidones","volume":"46","author":"Kamal","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib59","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1007\/s00018-004-4074-3","article-title":"Differential effects of monastrol in two human cell lines","volume":"61","author":"Leizerman","year":"2004","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2017.10.073_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcp.2008.04.018","article-title":"Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor","volume":"76","author":"Liu","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bioorg.2016.09.001","article-title":"Synthesis, characterization and in silico designing of diethyl-3-methyl-5-(6-methyl-2-thioxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxamido) thiophene-2,4-dicarboxylate derivative as anti-proliferative and anti-microbial agents","volume":"68","author":"Malani","year":"2016","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib62","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00210-016-1292-9","article-title":"Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells","volume":"389","author":"Marques","year":"2016","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2016.12.007","article-title":"Synthesis, in\u00a0vitro evaluation and QSAR modelling of potential antitumoral 3,4-dihydropyrimidin-2-(1H)-thiones","author":"Matias","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib64","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00280-006-0254-1","article-title":"Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells","volume":"59","author":"Muller","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib65","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2174\/15701808113109990007","article-title":"Synthesis and cytotoxic evaluation for some new dihydropyrimidinone derivatives for anticancer activity","volume":"10","author":"Reddy","year":"2013","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2017.10.073_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bioorg.2006.04.003","article-title":"Synthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines: monastrol, oxo-monastrol and oxygenated analogues","volume":"34","author":"Russowsky","year":"2006","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejmech.2012.11.044","article-title":"Discovery of coumarin\u2013monastrol hybrid as potential antibreast tumor-specific agent","volume":"60","author":"Sashidhara","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib68","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1039\/C6MD00447D","article-title":"Design, synthesis and anticancer activity of dihydropyrimidinone-semicarbazone hybrids as potential human DNA ligase 1 inhibitors","volume":"7","author":"Sashidhara","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2017.10.073_bib69","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1039\/c4ob00094c","article-title":"Regioselective synthesis of novel 4,5-diaryl functionalized 3,4-dihydropyrimidine-2(1H)-thiones via a non-Biginelli-type approach and evaluation of their in\u00a0vitro anticancer activity","volume":"12","author":"Sosnicki","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2191-2858-2-23","article-title":"Monastrol mimic Biginelli dihydropyrimidinone derivatives: synthesis, cytotoxicity screening against HepG2 and HeLa cell lines and molecular modeling study","volume":"2","author":"Soumyanarayanan","year":"2012","journal-title":"Org. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib71","first-page":"4463","article-title":"Activity of LaSOM 65, a monastrol-derived compound, against glioblastoma multiforme cell lines","volume":"33","author":"Stuepp","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bbrc.2014.04.023","article-title":"Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation","volume":"447","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2017.10.073_bib73","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1734-1140(09)70178-1","article-title":"Tumor anti-initiating activity of some novel 3, 4-dihydropyrimidinones","volume":"61","author":"Tawfik","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2017.10.073_bib74","doi-asserted-by":"crossref","first-page":"82330","DOI":"10.1039\/C6RA17235K","article-title":"New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors","volume":"6","author":"Terracciano","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2017.10.073_bib75","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/00498254.2013.822131","article-title":"Pre-clinical pharmacokinetics and acute toxicological evaluation of a monastrol derivative anticancer candidate LaSOM 65 in rats","volume":"44","author":"Torres","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejmech.2017.10.073_bib76","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2015.03.062","article-title":"Novel hybrid DHPM-fatty acids: synthesis and activity against glioma cell growth in\u00a0vitro","volume":"95","author":"Treptow","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.colsurfb.2013.01.019","article-title":"Exploring DNA binding properties and biological activities of dihydropyrimidinones derivatives","volume":"106","author":"Wang","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejmech.2017.10.073_bib78","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.bmc.2007.12.014","article-title":"Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation","volume":"16","author":"Wright","year":"2008","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib79","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.bmcl.2012.02.101","article-title":"Synthesis and in\u00a0vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group","volume":"22","author":"Yadlapalli","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib80","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.ejmech.2009.02.021","article-title":"Synthesis and pharmacological investigation of 3-(substituted 1-phenylethanone)-4-(substituted phenyl)-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates","volume":"44","author":"Chikhale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib81","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1016\/j.bmcl.2012.06.082","article-title":"A\u00a0substituted 3,4-dihydropyrimidinone derivative (compound D22) prevents inflammation mediated neurotoxicity; role in microglial activation in BV-2 cells","volume":"22","author":"Kwon","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib82","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1039\/C6MD00395H","article-title":"Novel soluble epoxide hydrolase inhibitors with a dihydropyrimidinone scaffold: design, synthesis and biological evaluation","volume":"7","author":"Rezaee","year":"2016","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2017.10.073_bib83","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1016\/j.bmcl.2011.03.062","article-title":"The novel 3,4-dihydropyrimidin-2(1H)-one urea derivatives of N-aryl urea: synthesis, anti-inflammatory, antibacterial and antifungal activity evaluation","volume":"21","author":"Tale","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib84","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bmcl.2011.12.068","article-title":"Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists","volume":"22","author":"Gijsen","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib85","first-page":"1713","article-title":"Microwave assisted synthesis and pharmacological screening of novel 6-Methyl-2-oxo-4-substituted 5-(5-Phenyl-1,3,4-oxadiazole-2-yl)-1,2,3, 4-tetrahydropyrimidines","volume":"23","author":"Kshirsagar","year":"2011","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib86","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/1570180811209050962","article-title":"Synthesis of 3, 4\u2013Dihydropyrimidin\u20132-ones (DHPMs) using highly efficient recyclable silica supported rhodium chloride as heterogeneous catalyst and their anti-neuroinflammatory activity","volume":"9","author":"Donthabhakthuni","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2017.10.073_bib87","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ardp.201300118","article-title":"Synthesis of sydnone substituted biginelli derivatives as Hyaluronidase inhibitors","volume":"346","author":"Gireesh","year":"2013","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2017.10.073_bib88","first-page":"92","article-title":"Anti-inflammatory activity of some new dihydropyrimidines derivatives","volume":"1","author":"Mishra","year":"2010","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib89","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.bmcl.2010.06.058","article-title":"Synthesis and anti-inflammatory activity of some 3-(4, 6-disubtituted-2-thioxo-1, 2, 3, 4-tetrahydropyrimidin-5-yl) propanoic acid derivatives","volume":"20","author":"Mokale","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib90","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.arabjc.2014.05.007","article-title":"Triethylammonium acetate ionic liquid assisted one-pot synthesis of dihydropyrimidinones and evaluation of their antioxidant and antibacterial activities","volume":"10","author":"Attri","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib91","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejmech.2009.09.018","article-title":"Synthesis and in\u00a0vitro microbiological evaluation of novel 4-aryl-5-isopropoxycarbonyl-6-methyl-3,4-dihydropyrimidinones","volume":"45","author":"Chitra","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib92","first-page":"24","article-title":"Microwave assisted synthesis of some novel acetazolamide cyclocondensed 1,2,3,4-tetrahydropyrimidines as a potent antimicrobial and cytotoxic agents","volume":"3","author":"Elumalai","year":"2014","journal-title":"Beni-Suef Univ. J. Appl. Sci."},{"key":"10.1016\/j.ejmech.2017.10.073_bib93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jtusci.2015.01.005","article-title":"Antimicrobial and in\u00a0vitro cytotoxicity of novel sulphanilamide condensed 1,2,3,4-tetrahydropyrimidines","volume":"11","author":"Elumalai","year":"2017","journal-title":"J.\u00a0Taibah Univ. Sci."},{"key":"10.1016\/j.ejmech.2017.10.073_bib94","first-page":"551","article-title":"Synthesis of novel Schiff bases and evaluation of their antimicrobial activities","volume":"54","author":"Huq","year":"2015","journal-title":"Indian J. Chem. B"},{"key":"10.1016\/j.ejmech.2017.10.073_bib95","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.bmcl.2012.02.056","article-title":"Design, synthesis, synergistic antimicrobial activity and cytotoxicity of 4-aryl substituted 3,4-dihydropyrimidinones of curcumin","volume":"22","author":"Lal","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.saa.2016.04.045","article-title":"One-pot three-component Biginelli-type reaction to synthesize 3,4-dihydropyrimidine-2-(1H)-ones catalyzed by Co phthalocyanines: synthesis, characterization, aggregation behavior and antibacterial activity","volume":"167","author":"Medyouni","year":"2016","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2017.10.073_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12154-015-0142-4","article-title":"Synthesis, antibacterial studies, and molecular modeling studies of 3,4-dihydropyrimidinone compounds","volume":"9","author":"Ramachandran","year":"2016","journal-title":"J.\u00a0Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib98","first-page":"241","article-title":"Design, synthesis and antimycobacterial activity of some novel 3,5-dichloro-2-ethoxy-6-fluoropyridin-4 amine cyclocondensed dihydropyrimidines","volume":"7","author":"Elumalai","year":"2013","journal-title":"J.\u00a0Pharm. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib99","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.bmcl.2011.03.045","article-title":"A\u00a0green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity","volume":"21","author":"Rajesh","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bioorg.2013.08.002","article-title":"Novel alkynyl substituted 3,4-dihydropyrimidin-2(1H)-one derivatives as potential inhibitors of chorismate mutase","volume":"51","author":"Mallikarjuna Rao","year":"2013","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejmech.2011.09.040","article-title":"Efficient one-pot preparation of novel fused chromeno [2, 3-d] pyrimidine and pyrano [2, 3-d] pyrimidine derivatives","volume":"47","author":"Aly","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib102","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/j.bmcl.2010.08.060","article-title":"Synthesis, antimicrobial, and mosquito larvicidal activity of 1-aryl-4-methyl-3, 6-bis-(5-methylisoxazol-3-yl)-2-thioxo-2, 3, 6, 10b-tetrahydro-1H-pyrimido [5, 4-c] quinolin-5-ones","volume":"20","author":"Rajanarendar","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib103","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1016\/j.bmcl.2010.08.046","article-title":"Novel dihydropyrimidines as a potential new class of antitubercular agents","volume":"20","author":"Trivedi","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib104","first-page":"562","article-title":"Synthesis, characterization and antifungal testing of 3,4-dihydropyrimidin-2(1H)-(thio)ones containing boronic acids and boronate esters","volume":"6","author":"Duguay","year":"2008","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib105","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.bmcl.2011.12.090","article-title":"Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication","volume":"22","author":"Kim","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib106","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.bmcl.2016.08.080","article-title":"Dihydropyrimidinones and -thiones with improved activity against human polyomavirus family members","volume":"26","author":"Manos-Turvey","year":"2016","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib107","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2012.05.010","article-title":"Identification of substituted [3, 2-a] pyrimidines as selective antiviral agents: molecular modeling study","volume":"95","author":"Ravendra Babu","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib108","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00044-012-0123-x","article-title":"Inhibitory effect and structure\u2013activity relationship of some Biginelli-type pyrimidines against HSV-1","volume":"22","author":"Zabihollahi","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib109","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.biochi.2011.04.004","article-title":"Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM","volume":"93","author":"Manral","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2017.10.073_bib110","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.2042-7158.2011.01316.x","article-title":"Characterization of a unique dihydropyrimidinone, ethyl 4-(4 '-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model","volume":"63","author":"Priya","year":"2011","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib111","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejmech.2008.10.002","article-title":"N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity","volume":"44","author":"Singh","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib112","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1002\/ejoc.200900208","article-title":"An efficacious protocol for 4-substituted 3,4-dihydropyrimidinones: synthesis and calcium channel binding studies","volume":"19","author":"Singh","year":"2009","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib113","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejmech.2012.04.043","article-title":"Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: screening of their biological activities against Ca2+-ATPase","volume":"54","author":"Putatunda","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejmech.2012.05.017","article-title":"Highly regioselective synthesis of N-3 organophosphorous derivatives of 3,4-dihydropyrimidin-2(1H)-ones and their calcium channel binding studies","volume":"54","author":"Singh","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib115","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1016\/j.bmc.2006.08.031","article-title":"Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers","volume":"14","author":"Zorkun","year":"2006","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-827X(02)00009-5","article-title":"Synthesis and in\u00a0vitro calcium antagonist activity of 4-aryl-7,7-dimethyl\/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-dione derivatives","volume":"58","author":"Yar\u0131m","year":"2003","journal-title":"Farmaco"},{"key":"10.1016\/j.ejmech.2017.10.073_bib117","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1021\/jm00167a035","article-title":"Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1, 4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines","volume":"33","author":"Atwal","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib118","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1021\/jm00171a044","article-title":"Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1, 4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines","volume":"33","author":"Atwal","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib119","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/jm00095a023","article-title":"Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1, 4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents","volume":"35","author":"Rovnyak","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib120","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1016\/j.bmc.2016.09.031","article-title":"Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease","volume":"24","author":"Barbosa","year":"2016","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ejmech.2006.01.007","article-title":"Dihydropyrimidin-(2H)-ones obtained by ultrasound irradiation: a new class of potential antioxidant agents","volume":"41","author":"Stefani","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib122","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jbt.20424","article-title":"Antioxidant capacity and environmentally friendly synthesis of dihydropyrimidin-(2H)-ones promoted by naturally occurring organic acids","volume":"26","author":"de Vasconcelos","year":"2012","journal-title":"J.\u00a0Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib123","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1007\/s00044-012-9987-z","article-title":"3, 4-Dihydropyrimidin-2 (1H)-one derivatives: organocatalysed microwave assisted synthesis and evaluation of their antioxidant activity","volume":"21","author":"Gangwar","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.10.073_bib124","first-page":"257","article-title":"Synthesis and antioxidant evaluation of 4-(furan-2-yl)-6-methyl-2-thioxo-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylate esters","volume":"7","author":"Mansouri","year":"2012","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2017.10.073_bib125","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.bmcl.2013.03.069","article-title":"Novel racemic tetrahydrocurcuminoid dihydropyrimidinone analogues as potent acetylcholinesterase inhibitors","volume":"23","author":"Arunkhamkaew","year":"2013","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib126","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.bmc.2009.01.024","article-title":"Select pyrimidinones inhibit the propagation of the malarial parasite, Plasmodium falciparum","volume":"17","author":"Chiang","year":"2009","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib127","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jac\/dkq189","article-title":"Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani","volume":"65","author":"Kaur","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2017.10.073_bib128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2016.03.022","article-title":"Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents","volume":"115","author":"Rashid","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bioorg.2014.05.003","article-title":"Novel synthesis of dihydropyrimidines for \u03b1-glucosidase inhibition to treat type 2 diabetes: in\u00a0vitro biological evaluation and in silico docking","volume":"54","author":"Yar","year":"2014","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib130","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.bmcl.2011.02.076","article-title":"Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors","volume":"21","author":"Liu","year":"2011","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib131","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0960-894X(00)00374-7","article-title":"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective \u03b11a-receptor antagonists","volume":"10","author":"Barrow","year":"2000","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib132","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1021\/jm990612y","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia","volume":"43","author":"Barrow","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib133","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/21691401.2013.769448","article-title":"Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds","volume":"42","author":"Celik","year":"2014","journal-title":"Artif. Cells Nanomed Biotechnol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib134","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/14756366.2012.746972","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel 1,4-dihydropyrimidinone substituted diarylureas","volume":"29","author":"Celik","year":"2014","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib135","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1016\/j.bmcl.2006.06.059","article-title":"Synthesis and cardiac effects of 3,4-dihydropyrimidin-2(1H)-one-5 carboxylates","volume":"16","author":"Sujatha","year":"2006","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib136","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/359540a0","article-title":"Mitotic spindle organization by a plus-end-directed microtubule motor","volume":"359","author":"Sawin","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.10.073_bib137","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0092-8674(95)90142-6","article-title":"Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in\u00a0vivo","volume":"83","author":"Blangy","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2017.10.073_bib138","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1074-5521(02)00212-0","article-title":"Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5","volume":"9","author":"Maliga","year":"2002","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib139","article-title":"Mechanism of the small molecule Eg5 inhibitor monastrol","volume":"12","author":"Maliga","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2017.10.073_bib140","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1016\/j.bmcl.2010.05.085","article-title":"Monastrol analogs: a synthesis of pyrazolopyridine, benzopyranopyrazolopyridine, and oxygen-bridged azolopyrimidine derivatives and their biological screening","volume":"20","author":"Svetlik","year":"2010","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.10.073_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2017.10.073_bib142","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1021\/jo00110a021","article-title":"Novel alkaloids from the sponge Batzella sp.: inhibitors of HIV gp120-human CD4 binding","volume":"60","author":"Patil","year":"1995","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2017.10.073_bib143","first-page":"907","article-title":"An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81","volume":"60","author":"Pinichpongse","year":"1982","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.ejmech.2017.10.073_bib144","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S0037-86822003000200012","article-title":"Febre amarela","volume":"36","author":"P.F. da Costa Vasconcelos","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejmech.2017.10.073_bib145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0035-9203(87)90187-8","article-title":"American visceral leishmaniasis: on the origin of Leishmania (Leishmania) chagasi","volume":"81","author":"Lainson","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2017.10.073_bib146","first-page":"367","article-title":"Effect of Nifedipine on human coronary venous oxygen saturation at constant heart rates","volume":"22","author":"Schwarzkopf","year":"1972","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2017.10.073_bib147","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1536\/ihj.13.128","article-title":"Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator","volume":"13","author":"Murakami","year":"1972","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.ejmech.2017.10.073_bib148","first-page":"39","article-title":"[The mechanism of coronary dilatating action of nifedipine]","volume":"22","author":"Kosche","year":"1972","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2017.10.073_bib149","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/15412550601169513","article-title":"COPD: magnesium in the plasma and polymorphonuclear cells of patients during a stable phase","volume":"4","author":"Ruljan\u010di\u0107","year":"2007","journal-title":"COPD"},{"key":"10.1016\/j.ejmech.2017.10.073_bib150","first-page":"564","article-title":"The treatment of benign prostatic hypertrophy with flutamide (SCH: 13521): a placebo-controlled study","volume":"114","author":"Caine","year":"1975","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2017.10.073_bib151","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia","volume":"335","author":"Lepor","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2017.10.073_bib152","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0922-4106(89)90013-8","article-title":"Stereoselective binding of niguldipine enantiomers to \u03b11A-adrenoceptors labeled with [3H] 5-methyl-urapidil","volume":"172","author":"Graziadei","year":"1989","journal-title":"Eur. J. Pharm-Molec Ph"},{"key":"10.1016\/j.ejmech.2017.10.073_bib153","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0306-9877(92)90081-M","article-title":"Lipid peroxidation and tumor growth: an inverse relationship","volume":"38","author":"Gonzalez","year":"1992","journal-title":"Med. Hypotheses"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T21:33:15Z","timestamp":1540416795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417308759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":153,"alternative-id":["S0223523417308759"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.073","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}